Choroidal Vascularity Index in CHM Carriers.
CHM
CVI
OCT
carriers
choroid
choroideremia
Journal
Frontiers in ophthalmology
ISSN: 2674-0826
Titre abrégé: Front Ophthalmol (Lausanne)
Pays: Switzerland
ID NLM: 9918419176106676
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
08
2021
accepted:
27
09
2021
medline:
20
10
2021
pubmed:
20
10
2021
entrez:
10
7
2024
Statut:
epublish
Résumé
To assess the choroidal structure using the Choroidal Vascularity Index (CVI) and analyse choroidal changes in choroideremia (CHM) carriers. Female CHM carriers, genetically characterized, and a control group were recruited at the Eye Clinic of Careggi Teaching Hospital, Florence. The patients underwent a complete ophthalmic evaluation and retinal imaging. In particular, the Stromal Area (SA), Luminal Area (LA), Total Choroidal Area (TCA), CVI, and Subfoveal Choroidal Thickness (SFCT) were calculated for each eye using Optical Coherence Tomography (OCT) examinations. Twelve eyes of 6 CHM carriers and 14 eyes of 7 age-matched controls were analysed. The mean SFCT was 270.9 ± 54.3μm in carriers and 281.4 ± 36.8μm in controls (p = 0.564); LA was 0.99 ± 0.25mm The CVI and CVI-related parameters (SA, LA, and TCA) do not differ between CHM female carriers and controls. These findings reveal a preserved choroidal vasculature in eyes with RPE impairment and support the primary role of RPE in the pathogenesis of CHM disease.
Identifiants
pubmed: 38983966
doi: 10.3389/fopht.2021.755058
pmc: PMC11182189
doi:
Types de publication
Journal Article
Langues
eng
Pagination
755058Informations de copyright
Copyright © 2021 Mucciolo, Giorgio, Lippera, Passerini, Pelo, Cipollini, Sodi, Virgili, Giansanti and Murro.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.